COVID-19 Impact on Global TDS(Transdermal Delivery Systems) Market Insights, Forecast to 2026
TDS(Transdermal Delivery Systems) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global TDS(Transdermal Delivery Systems) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the TDS(Transdermal Delivery Systems) market is segmented into
The TDS(Transdermal Delivery Systems) market is analysed and market size information is provided by regions (countries).
The key regions covered in the TDS(Transdermal Delivery Systems) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and TDS(Transdermal Delivery Systems) Market Share Analysis
TDS(Transdermal Delivery Systems) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in TDS(Transdermal Delivery Systems) business, the date to enter into the TDS(Transdermal Delivery Systems) market, TDS(Transdermal Delivery Systems) product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the TDS(Transdermal Delivery Systems) market is segmented into
- Single-layer Drug-in-Adhesive
- Multi-layer Drug-in-Adhesive
- Others
- Hospital
- Clinic
- Other
The TDS(Transdermal Delivery Systems) market is analysed and market size information is provided by regions (countries).
The key regions covered in the TDS(Transdermal Delivery Systems) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and TDS(Transdermal Delivery Systems) Market Share Analysis
TDS(Transdermal Delivery Systems) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in TDS(Transdermal Delivery Systems) business, the date to enter into the TDS(Transdermal Delivery Systems) market, TDS(Transdermal Delivery Systems) product introduction, recent developments, etc.
The major vendors covered:
- Adhex Pharma
- Harro Hofliger
- Tesa Labtec
- Toyochem
- Teva Pharmaceutical
- Pfizer
- IBSA Group
- Teikoku Seiyaku
- Endo International
- Hisamitsu
- Mylan
- Sorrento Therapeutics
1 STUDY COVERAGE
1.1 TDS(Transdermal Delivery Systems) Product Introduction
1.2 Market Segments
1.3 Key TDS(Transdermal Delivery Systems) Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global TDS(Transdermal Delivery Systems) Market Size Growth Rate by Type
1.4.2 Single-layer Drug-in-Adhesive
1.4.3 Multi-layer Drug-in-Adhesive
1.4.4 Others
1.5 Market by Application
1.5.1 Global TDS(Transdermal Delivery Systems) Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): TDS(Transdermal Delivery Systems) Industry Impact
1.6.1 How the Covid-19 is Affecting the TDS(Transdermal Delivery Systems) Industry
1.6.1.1 TDS(Transdermal Delivery Systems) Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and TDS(Transdermal Delivery Systems) Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for TDS(Transdermal Delivery Systems) Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global TDS(Transdermal Delivery Systems) Market Size Estimates and Forecasts
2.1.1 Global TDS(Transdermal Delivery Systems) Revenue 2015-2026
2.1.2 Global TDS(Transdermal Delivery Systems) Sales 2015-2026
2.2 TDS(Transdermal Delivery Systems) Market Size by Region: 2020 Versus 2026
2.2.1 Global TDS(Transdermal Delivery Systems) Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global TDS(Transdermal Delivery Systems) Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL TDS(TRANSDERMAL DELIVERY SYSTEMS) COMPETITOR LANDSCAPE BY PLAYERS
3.1 TDS(Transdermal Delivery Systems) Sales by Manufacturers
3.1.1 TDS(Transdermal Delivery Systems) Sales by Manufacturers (2015-2020)
3.1.2 TDS(Transdermal Delivery Systems) Sales Market Share by Manufacturers (2015-2020)
3.2 TDS(Transdermal Delivery Systems) Revenue by Manufacturers
3.2.1 TDS(Transdermal Delivery Systems) Revenue by Manufacturers (2015-2020)
3.2.2 TDS(Transdermal Delivery Systems) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global TDS(Transdermal Delivery Systems) Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by TDS(Transdermal Delivery Systems) Revenue in 2019
3.2.5 Global TDS(Transdermal Delivery Systems) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 TDS(Transdermal Delivery Systems) Price by Manufacturers
3.4 TDS(Transdermal Delivery Systems) Manufacturing Base Distribution, Product Types
3.4.1 TDS(Transdermal Delivery Systems) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers TDS(Transdermal Delivery Systems) Product Type
3.4.3 Date of International Manufacturers Enter into TDS(Transdermal Delivery Systems) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global TDS(Transdermal Delivery Systems) Market Size by Type (2015-2020)
4.1.1 Global TDS(Transdermal Delivery Systems) Sales by Type (2015-2020)
4.1.2 Global TDS(Transdermal Delivery Systems) Revenue by Type (2015-2020)
4.1.3 TDS(Transdermal Delivery Systems) Average Selling Price (ASP) by Type (2015-2026)
4.2 Global TDS(Transdermal Delivery Systems) Market Size Forecast by Type (2021-2026)
4.2.1 Global TDS(Transdermal Delivery Systems) Sales Forecast by Type (2021-2026)
4.2.2 Global TDS(Transdermal Delivery Systems) Revenue Forecast by Type (2021-2026)
4.2.3 TDS(Transdermal Delivery Systems) Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global TDS(Transdermal Delivery Systems) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global TDS(Transdermal Delivery Systems) Market Size by Application (2015-2020)
5.1.1 Global TDS(Transdermal Delivery Systems) Sales by Application (2015-2020)
5.1.2 Global TDS(Transdermal Delivery Systems) Revenue by Application (2015-2020)
5.1.3 TDS(Transdermal Delivery Systems) Price by Application (2015-2020)
5.2 TDS(Transdermal Delivery Systems) Market Size Forecast by Application (2021-2026)
5.2.1 Global TDS(Transdermal Delivery Systems) Sales Forecast by Application (2021-2026)
5.2.2 Global TDS(Transdermal Delivery Systems) Revenue Forecast by Application (2021-2026)
5.2.3 Global TDS(Transdermal Delivery Systems) Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America TDS(Transdermal Delivery Systems) by Country
6.1.1 North America TDS(Transdermal Delivery Systems) Sales by Country
6.1.2 North America TDS(Transdermal Delivery Systems) Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America TDS(Transdermal Delivery Systems) Market Facts & Figures by Type
6.3 North America TDS(Transdermal Delivery Systems) Market Facts & Figures by Application
7 EUROPE
7.1 Europe TDS(Transdermal Delivery Systems) by Country
7.1.1 Europe TDS(Transdermal Delivery Systems) Sales by Country
7.1.2 Europe TDS(Transdermal Delivery Systems) Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe TDS(Transdermal Delivery Systems) Market Facts & Figures by Type
7.3 Europe TDS(Transdermal Delivery Systems) Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific TDS(Transdermal Delivery Systems) by Region
8.1.1 Asia Pacific TDS(Transdermal Delivery Systems) Sales by Region
8.1.2 Asia Pacific TDS(Transdermal Delivery Systems) Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific TDS(Transdermal Delivery Systems) Market Facts & Figures by Type
8.3 Asia Pacific TDS(Transdermal Delivery Systems) Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America TDS(Transdermal Delivery Systems) by Country
9.1.1 Latin America TDS(Transdermal Delivery Systems) Sales by Country
9.1.2 Latin America TDS(Transdermal Delivery Systems) Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America TDS(Transdermal Delivery Systems) Market Facts & Figures by Type
9.3 Central & South America TDS(Transdermal Delivery Systems) Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa TDS(Transdermal Delivery Systems) by Country
10.1.1 Middle East and Africa TDS(Transdermal Delivery Systems) Sales by Country
10.1.2 Middle East and Africa TDS(Transdermal Delivery Systems) Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa TDS(Transdermal Delivery Systems) Market Facts & Figures by Type
10.3 Middle East and Africa TDS(Transdermal Delivery Systems) Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Adhex Pharma
11.1.1 Adhex Pharma Corporation Information
11.1.2 Adhex Pharma Description, Business Overview and Total Revenue
11.1.3 Adhex Pharma Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Adhex Pharma TDS(Transdermal Delivery Systems) Products Offered
11.1.5 Adhex Pharma Recent Development
11.2 Harro Hofliger
11.2.1 Harro Hofliger Corporation Information
11.2.2 Harro Hofliger Description, Business Overview and Total Revenue
11.2.3 Harro Hofliger Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Harro Hofliger TDS(Transdermal Delivery Systems) Products Offered
11.2.5 Harro Hofliger Recent Development
11.3 Tesa Labtec
11.3.1 Tesa Labtec Corporation Information
11.3.2 Tesa Labtec Description, Business Overview and Total Revenue
11.3.3 Tesa Labtec Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Tesa Labtec TDS(Transdermal Delivery Systems) Products Offered
11.3.5 Tesa Labtec Recent Development
11.4 Toyochem
11.4.1 Toyochem Corporation Information
11.4.2 Toyochem Description, Business Overview and Total Revenue
11.4.3 Toyochem Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Toyochem TDS(Transdermal Delivery Systems) Products Offered
11.4.5 Toyochem Recent Development
11.5 Teva Pharmaceutical
11.5.1 Teva Pharmaceutical Corporation Information
11.5.2 Teva Pharmaceutical Description, Business Overview and Total Revenue
11.5.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Teva Pharmaceutical TDS(Transdermal Delivery Systems) Products Offered
11.5.5 Teva Pharmaceutical Recent Development
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Description, Business Overview and Total Revenue
11.6.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Pfizer TDS(Transdermal Delivery Systems) Products Offered
11.6.5 Pfizer Recent Development
11.7 IBSA Group
11.7.1 IBSA Group Corporation Information
11.7.2 IBSA Group Description, Business Overview and Total Revenue
11.7.3 IBSA Group Sales, Revenue and Gross Margin (2015-2020)
11.7.4 IBSA Group TDS(Transdermal Delivery Systems) Products Offered
11.7.5 IBSA Group Recent Development
11.8 Teikoku Seiyaku
11.8.1 Teikoku Seiyaku Corporation Information
11.8.2 Teikoku Seiyaku Description, Business Overview and Total Revenue
11.8.3 Teikoku Seiyaku Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Teikoku Seiyaku TDS(Transdermal Delivery Systems) Products Offered
11.8.5 Teikoku Seiyaku Recent Development
11.9 Endo International
11.9.1 Endo International Corporation Information
11.9.2 Endo International Description, Business Overview and Total Revenue
11.9.3 Endo International Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Endo International TDS(Transdermal Delivery Systems) Products Offered
11.9.5 Endo International Recent Development
11.10 Hisamitsu
11.10.1 Hisamitsu Corporation Information
11.10.2 Hisamitsu Description, Business Overview and Total Revenue
11.10.3 Hisamitsu Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Hisamitsu TDS(Transdermal Delivery Systems) Products Offered
11.10.5 Hisamitsu Recent Development
11.1 Adhex Pharma
11.1.1 Adhex Pharma Corporation Information
11.1.2 Adhex Pharma Description, Business Overview and Total Revenue
11.1.3 Adhex Pharma Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Adhex Pharma TDS(Transdermal Delivery Systems) Products Offered
11.1.5 Adhex Pharma Recent Development
11.12 Sorrento Therapeutics
11.12.1 Sorrento Therapeutics Corporation Information
11.12.2 Sorrento Therapeutics Description, Business Overview and Total Revenue
11.12.3 Sorrento Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Sorrento Therapeutics Products Offered
11.12.5 Sorrento Therapeutics Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 TDS(Transdermal Delivery Systems) Market Estimates and Projections by Region
12.1.1 Global TDS(Transdermal Delivery Systems) Sales Forecast by Regions 2021-2026
12.1.2 Global TDS(Transdermal Delivery Systems) Revenue Forecast by Regions 2021-2026
12.2 North America TDS(Transdermal Delivery Systems) Market Size Forecast (2021-2026)
12.2.1 North America: TDS(Transdermal Delivery Systems) Sales Forecast (2021-2026)
12.2.2 North America: TDS(Transdermal Delivery Systems) Revenue Forecast (2021-2026)
12.2.3 North America: TDS(Transdermal Delivery Systems) Market Size Forecast by Country (2021-2026)
12.3 Europe TDS(Transdermal Delivery Systems) Market Size Forecast (2021-2026)
12.3.1 Europe: TDS(Transdermal Delivery Systems) Sales Forecast (2021-2026)
12.3.2 Europe: TDS(Transdermal Delivery Systems) Revenue Forecast (2021-2026)
12.3.3 Europe: TDS(Transdermal Delivery Systems) Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific TDS(Transdermal Delivery Systems) Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: TDS(Transdermal Delivery Systems) Sales Forecast (2021-2026)
12.4.2 Asia Pacific: TDS(Transdermal Delivery Systems) Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: TDS(Transdermal Delivery Systems) Market Size Forecast by Region (2021-2026)
12.5 Latin America TDS(Transdermal Delivery Systems) Market Size Forecast (2021-2026)
12.5.1 Latin America: TDS(Transdermal Delivery Systems) Sales Forecast (2021-2026)
12.5.2 Latin America: TDS(Transdermal Delivery Systems) Revenue Forecast (2021-2026)
12.5.3 Latin America: TDS(Transdermal Delivery Systems) Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa TDS(Transdermal Delivery Systems) Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: TDS(Transdermal Delivery Systems) Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: TDS(Transdermal Delivery Systems) Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: TDS(Transdermal Delivery Systems) Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key TDS(Transdermal Delivery Systems) Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 TDS(Transdermal Delivery Systems) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 TDS(Transdermal Delivery Systems) Product Introduction
1.2 Market Segments
1.3 Key TDS(Transdermal Delivery Systems) Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global TDS(Transdermal Delivery Systems) Market Size Growth Rate by Type
1.4.2 Single-layer Drug-in-Adhesive
1.4.3 Multi-layer Drug-in-Adhesive
1.4.4 Others
1.5 Market by Application
1.5.1 Global TDS(Transdermal Delivery Systems) Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): TDS(Transdermal Delivery Systems) Industry Impact
1.6.1 How the Covid-19 is Affecting the TDS(Transdermal Delivery Systems) Industry
1.6.1.1 TDS(Transdermal Delivery Systems) Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and TDS(Transdermal Delivery Systems) Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for TDS(Transdermal Delivery Systems) Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global TDS(Transdermal Delivery Systems) Market Size Estimates and Forecasts
2.1.1 Global TDS(Transdermal Delivery Systems) Revenue 2015-2026
2.1.2 Global TDS(Transdermal Delivery Systems) Sales 2015-2026
2.2 TDS(Transdermal Delivery Systems) Market Size by Region: 2020 Versus 2026
2.2.1 Global TDS(Transdermal Delivery Systems) Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global TDS(Transdermal Delivery Systems) Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL TDS(TRANSDERMAL DELIVERY SYSTEMS) COMPETITOR LANDSCAPE BY PLAYERS
3.1 TDS(Transdermal Delivery Systems) Sales by Manufacturers
3.1.1 TDS(Transdermal Delivery Systems) Sales by Manufacturers (2015-2020)
3.1.2 TDS(Transdermal Delivery Systems) Sales Market Share by Manufacturers (2015-2020)
3.2 TDS(Transdermal Delivery Systems) Revenue by Manufacturers
3.2.1 TDS(Transdermal Delivery Systems) Revenue by Manufacturers (2015-2020)
3.2.2 TDS(Transdermal Delivery Systems) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global TDS(Transdermal Delivery Systems) Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by TDS(Transdermal Delivery Systems) Revenue in 2019
3.2.5 Global TDS(Transdermal Delivery Systems) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 TDS(Transdermal Delivery Systems) Price by Manufacturers
3.4 TDS(Transdermal Delivery Systems) Manufacturing Base Distribution, Product Types
3.4.1 TDS(Transdermal Delivery Systems) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers TDS(Transdermal Delivery Systems) Product Type
3.4.3 Date of International Manufacturers Enter into TDS(Transdermal Delivery Systems) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global TDS(Transdermal Delivery Systems) Market Size by Type (2015-2020)
4.1.1 Global TDS(Transdermal Delivery Systems) Sales by Type (2015-2020)
4.1.2 Global TDS(Transdermal Delivery Systems) Revenue by Type (2015-2020)
4.1.3 TDS(Transdermal Delivery Systems) Average Selling Price (ASP) by Type (2015-2026)
4.2 Global TDS(Transdermal Delivery Systems) Market Size Forecast by Type (2021-2026)
4.2.1 Global TDS(Transdermal Delivery Systems) Sales Forecast by Type (2021-2026)
4.2.2 Global TDS(Transdermal Delivery Systems) Revenue Forecast by Type (2021-2026)
4.2.3 TDS(Transdermal Delivery Systems) Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global TDS(Transdermal Delivery Systems) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global TDS(Transdermal Delivery Systems) Market Size by Application (2015-2020)
5.1.1 Global TDS(Transdermal Delivery Systems) Sales by Application (2015-2020)
5.1.2 Global TDS(Transdermal Delivery Systems) Revenue by Application (2015-2020)
5.1.3 TDS(Transdermal Delivery Systems) Price by Application (2015-2020)
5.2 TDS(Transdermal Delivery Systems) Market Size Forecast by Application (2021-2026)
5.2.1 Global TDS(Transdermal Delivery Systems) Sales Forecast by Application (2021-2026)
5.2.2 Global TDS(Transdermal Delivery Systems) Revenue Forecast by Application (2021-2026)
5.2.3 Global TDS(Transdermal Delivery Systems) Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America TDS(Transdermal Delivery Systems) by Country
6.1.1 North America TDS(Transdermal Delivery Systems) Sales by Country
6.1.2 North America TDS(Transdermal Delivery Systems) Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America TDS(Transdermal Delivery Systems) Market Facts & Figures by Type
6.3 North America TDS(Transdermal Delivery Systems) Market Facts & Figures by Application
7 EUROPE
7.1 Europe TDS(Transdermal Delivery Systems) by Country
7.1.1 Europe TDS(Transdermal Delivery Systems) Sales by Country
7.1.2 Europe TDS(Transdermal Delivery Systems) Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe TDS(Transdermal Delivery Systems) Market Facts & Figures by Type
7.3 Europe TDS(Transdermal Delivery Systems) Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific TDS(Transdermal Delivery Systems) by Region
8.1.1 Asia Pacific TDS(Transdermal Delivery Systems) Sales by Region
8.1.2 Asia Pacific TDS(Transdermal Delivery Systems) Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific TDS(Transdermal Delivery Systems) Market Facts & Figures by Type
8.3 Asia Pacific TDS(Transdermal Delivery Systems) Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America TDS(Transdermal Delivery Systems) by Country
9.1.1 Latin America TDS(Transdermal Delivery Systems) Sales by Country
9.1.2 Latin America TDS(Transdermal Delivery Systems) Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America TDS(Transdermal Delivery Systems) Market Facts & Figures by Type
9.3 Central & South America TDS(Transdermal Delivery Systems) Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa TDS(Transdermal Delivery Systems) by Country
10.1.1 Middle East and Africa TDS(Transdermal Delivery Systems) Sales by Country
10.1.2 Middle East and Africa TDS(Transdermal Delivery Systems) Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa TDS(Transdermal Delivery Systems) Market Facts & Figures by Type
10.3 Middle East and Africa TDS(Transdermal Delivery Systems) Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Adhex Pharma
11.1.1 Adhex Pharma Corporation Information
11.1.2 Adhex Pharma Description, Business Overview and Total Revenue
11.1.3 Adhex Pharma Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Adhex Pharma TDS(Transdermal Delivery Systems) Products Offered
11.1.5 Adhex Pharma Recent Development
11.2 Harro Hofliger
11.2.1 Harro Hofliger Corporation Information
11.2.2 Harro Hofliger Description, Business Overview and Total Revenue
11.2.3 Harro Hofliger Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Harro Hofliger TDS(Transdermal Delivery Systems) Products Offered
11.2.5 Harro Hofliger Recent Development
11.3 Tesa Labtec
11.3.1 Tesa Labtec Corporation Information
11.3.2 Tesa Labtec Description, Business Overview and Total Revenue
11.3.3 Tesa Labtec Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Tesa Labtec TDS(Transdermal Delivery Systems) Products Offered
11.3.5 Tesa Labtec Recent Development
11.4 Toyochem
11.4.1 Toyochem Corporation Information
11.4.2 Toyochem Description, Business Overview and Total Revenue
11.4.3 Toyochem Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Toyochem TDS(Transdermal Delivery Systems) Products Offered
11.4.5 Toyochem Recent Development
11.5 Teva Pharmaceutical
11.5.1 Teva Pharmaceutical Corporation Information
11.5.2 Teva Pharmaceutical Description, Business Overview and Total Revenue
11.5.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Teva Pharmaceutical TDS(Transdermal Delivery Systems) Products Offered
11.5.5 Teva Pharmaceutical Recent Development
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Description, Business Overview and Total Revenue
11.6.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Pfizer TDS(Transdermal Delivery Systems) Products Offered
11.6.5 Pfizer Recent Development
11.7 IBSA Group
11.7.1 IBSA Group Corporation Information
11.7.2 IBSA Group Description, Business Overview and Total Revenue
11.7.3 IBSA Group Sales, Revenue and Gross Margin (2015-2020)
11.7.4 IBSA Group TDS(Transdermal Delivery Systems) Products Offered
11.7.5 IBSA Group Recent Development
11.8 Teikoku Seiyaku
11.8.1 Teikoku Seiyaku Corporation Information
11.8.2 Teikoku Seiyaku Description, Business Overview and Total Revenue
11.8.3 Teikoku Seiyaku Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Teikoku Seiyaku TDS(Transdermal Delivery Systems) Products Offered
11.8.5 Teikoku Seiyaku Recent Development
11.9 Endo International
11.9.1 Endo International Corporation Information
11.9.2 Endo International Description, Business Overview and Total Revenue
11.9.3 Endo International Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Endo International TDS(Transdermal Delivery Systems) Products Offered
11.9.5 Endo International Recent Development
11.10 Hisamitsu
11.10.1 Hisamitsu Corporation Information
11.10.2 Hisamitsu Description, Business Overview and Total Revenue
11.10.3 Hisamitsu Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Hisamitsu TDS(Transdermal Delivery Systems) Products Offered
11.10.5 Hisamitsu Recent Development
11.1 Adhex Pharma
11.1.1 Adhex Pharma Corporation Information
11.1.2 Adhex Pharma Description, Business Overview and Total Revenue
11.1.3 Adhex Pharma Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Adhex Pharma TDS(Transdermal Delivery Systems) Products Offered
11.1.5 Adhex Pharma Recent Development
11.12 Sorrento Therapeutics
11.12.1 Sorrento Therapeutics Corporation Information
11.12.2 Sorrento Therapeutics Description, Business Overview and Total Revenue
11.12.3 Sorrento Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Sorrento Therapeutics Products Offered
11.12.5 Sorrento Therapeutics Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 TDS(Transdermal Delivery Systems) Market Estimates and Projections by Region
12.1.1 Global TDS(Transdermal Delivery Systems) Sales Forecast by Regions 2021-2026
12.1.2 Global TDS(Transdermal Delivery Systems) Revenue Forecast by Regions 2021-2026
12.2 North America TDS(Transdermal Delivery Systems) Market Size Forecast (2021-2026)
12.2.1 North America: TDS(Transdermal Delivery Systems) Sales Forecast (2021-2026)
12.2.2 North America: TDS(Transdermal Delivery Systems) Revenue Forecast (2021-2026)
12.2.3 North America: TDS(Transdermal Delivery Systems) Market Size Forecast by Country (2021-2026)
12.3 Europe TDS(Transdermal Delivery Systems) Market Size Forecast (2021-2026)
12.3.1 Europe: TDS(Transdermal Delivery Systems) Sales Forecast (2021-2026)
12.3.2 Europe: TDS(Transdermal Delivery Systems) Revenue Forecast (2021-2026)
12.3.3 Europe: TDS(Transdermal Delivery Systems) Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific TDS(Transdermal Delivery Systems) Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: TDS(Transdermal Delivery Systems) Sales Forecast (2021-2026)
12.4.2 Asia Pacific: TDS(Transdermal Delivery Systems) Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: TDS(Transdermal Delivery Systems) Market Size Forecast by Region (2021-2026)
12.5 Latin America TDS(Transdermal Delivery Systems) Market Size Forecast (2021-2026)
12.5.1 Latin America: TDS(Transdermal Delivery Systems) Sales Forecast (2021-2026)
12.5.2 Latin America: TDS(Transdermal Delivery Systems) Revenue Forecast (2021-2026)
12.5.3 Latin America: TDS(Transdermal Delivery Systems) Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa TDS(Transdermal Delivery Systems) Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: TDS(Transdermal Delivery Systems) Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: TDS(Transdermal Delivery Systems) Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: TDS(Transdermal Delivery Systems) Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key TDS(Transdermal Delivery Systems) Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 TDS(Transdermal Delivery Systems) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. TDS(Transdermal Delivery Systems) Market Segments
Table 2. Ranking of Global Top TDS(Transdermal Delivery Systems) Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global TDS(Transdermal Delivery Systems) Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Single-layer Drug-in-Adhesive
Table 5. Major Manufacturers of Multi-layer Drug-in-Adhesive
Table 6. Major Manufacturers of Others
Table 7. COVID-19 Impact Global Market: (Four TDS(Transdermal Delivery Systems) Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for TDS(Transdermal Delivery Systems) Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for TDS(Transdermal Delivery Systems) Players to Combat Covid-19 Impact
Table 12. Global TDS(Transdermal Delivery Systems) Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global TDS(Transdermal Delivery Systems) Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 14. Global TDS(Transdermal Delivery Systems) Sales by Regions 2015-2020 (K Units)
Table 15. Global TDS(Transdermal Delivery Systems) Sales Market Share by Regions (2015-2020)
Table 16. Global TDS(Transdermal Delivery Systems) Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global TDS(Transdermal Delivery Systems) Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global TDS(Transdermal Delivery Systems) Sales Share by Manufacturers (2015-2020)
Table 19. Global TDS(Transdermal Delivery Systems) Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global TDS(Transdermal Delivery Systems) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in TDS(Transdermal Delivery Systems) as of 2019)
Table 21. TDS(Transdermal Delivery Systems) Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. TDS(Transdermal Delivery Systems) Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers TDS(Transdermal Delivery Systems) Price (2015-2020) (USD/Unit)
Table 24. TDS(Transdermal Delivery Systems) Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers TDS(Transdermal Delivery Systems) Product Type
Table 26. Date of International Manufacturers Enter into TDS(Transdermal Delivery Systems) Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global TDS(Transdermal Delivery Systems) Sales by Type (2015-2020) (K Units)
Table 29. Global TDS(Transdermal Delivery Systems) Sales Share by Type (2015-2020)
Table 30. Global TDS(Transdermal Delivery Systems) Revenue by Type (2015-2020) (US$ Million)
Table 31. Global TDS(Transdermal Delivery Systems) Revenue Share by Type (2015-2020)
Table 32. TDS(Transdermal Delivery Systems) Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 33. Global TDS(Transdermal Delivery Systems) Sales by Application (2015-2020) (K Units)
Table 34. Global TDS(Transdermal Delivery Systems) Sales Share by Application (2015-2020)
Table 35. North America TDS(Transdermal Delivery Systems) Sales by Country (2015-2020) (K Units)
Table 36. North America TDS(Transdermal Delivery Systems) Sales Market Share by Country (2015-2020)
Table 37. North America TDS(Transdermal Delivery Systems) Revenue by Country (2015-2020) (US$ Million)
Table 38. North America TDS(Transdermal Delivery Systems) Revenue Market Share by Country (2015-2020)
Table 39. North America TDS(Transdermal Delivery Systems) Sales by Type (2015-2020) (K Units)
Table 40. North America TDS(Transdermal Delivery Systems) Sales Market Share by Type (2015-2020)
Table 41. North America TDS(Transdermal Delivery Systems) Sales by Application (2015-2020) (K Units)
Table 42. North America TDS(Transdermal Delivery Systems) Sales Market Share by Application (2015-2020)
Table 43. Europe TDS(Transdermal Delivery Systems) Sales by Country (2015-2020) (K Units)
Table 44. Europe TDS(Transdermal Delivery Systems) Sales Market Share by Country (2015-2020)
Table 45. Europe TDS(Transdermal Delivery Systems) Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe TDS(Transdermal Delivery Systems) Revenue Market Share by Country (2015-2020)
Table 47. Europe TDS(Transdermal Delivery Systems) Sales by Type (2015-2020) (K Units)
Table 48. Europe TDS(Transdermal Delivery Systems) Sales Market Share by Type (2015-2020)
Table 49. Europe TDS(Transdermal Delivery Systems) Sales by Application (2015-2020) (K Units)
Table 50. Europe TDS(Transdermal Delivery Systems) Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific TDS(Transdermal Delivery Systems) Sales by Region (2015-2020) (K Units)
Table 52. Asia Pacific TDS(Transdermal Delivery Systems) Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific TDS(Transdermal Delivery Systems) Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific TDS(Transdermal Delivery Systems) Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific TDS(Transdermal Delivery Systems) Sales by Type (2015-2020) (K Units)
Table 56. Asia Pacific TDS(Transdermal Delivery Systems) Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific TDS(Transdermal Delivery Systems) Sales by Application (2015-2020) (K Units)
Table 58. Asia Pacific TDS(Transdermal Delivery Systems) Sales Market Share by Application (2015-2020)
Table 59. Latin America TDS(Transdermal Delivery Systems) Sales by Country (2015-2020) (K Units)
Table 60. Latin America TDS(Transdermal Delivery Systems) Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa TDS(Transdermal Delivery Systems) Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America TDS(Transdermal Delivery Systems) Revenue Market Share by Country (2015-2020)
Table 63. Latin America TDS(Transdermal Delivery Systems) Sales by Type (2015-2020) (K Units)
Table 64. Latin America TDS(Transdermal Delivery Systems) Sales Market Share by Type (2015-2020)
Table 65. Latin America TDS(Transdermal Delivery Systems) Sales by Application (2015-2020) (K Units)
Table 66. Latin America TDS(Transdermal Delivery Systems) Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa TDS(Transdermal Delivery Systems) Sales by Country (2015-2020) (K Units)
Table 68. Middle East and Africa TDS(Transdermal Delivery Systems) Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa TDS(Transdermal Delivery Systems) Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa TDS(Transdermal Delivery Systems) Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa TDS(Transdermal Delivery Systems) Sales by Type (2015-2020) (K Units)
Table 72. Middle East and Africa TDS(Transdermal Delivery Systems) Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa TDS(Transdermal Delivery Systems) Sales by Application (2015-2020) (K Units)
Table 74. Middle East and Africa TDS(Transdermal Delivery Systems) Sales Market Share by Application (2015-2020)
Table 75. Adhex Pharma Corporation Information
Table 76. Adhex Pharma Description and Major Businesses
Table 77. Adhex Pharma TDS(Transdermal Delivery Systems) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Adhex Pharma Product
Table 79. Adhex Pharma Recent Development
Table 80. Harro Hofliger Corporation Information
Table 81. Harro Hofliger Description and Major Businesses
Table 82. Harro Hofliger TDS(Transdermal Delivery Systems) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Harro Hofliger Product
Table 84. Harro Hofliger Recent Development
Table 85. Tesa Labtec Corporation Information
Table 86. Tesa Labtec Description and Major Businesses
Table 87. Tesa Labtec TDS(Transdermal Delivery Systems) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Tesa Labtec Product
Table 89. Tesa Labtec Recent Development
Table 90. Toyochem Corporation Information
Table 91. Toyochem Description and Major Businesses
Table 92. Toyochem TDS(Transdermal Delivery Systems) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Toyochem Product
Table 94. Toyochem Recent Development
Table 95. Teva Pharmaceutical Corporation Information
Table 96. Teva Pharmaceutical Description and Major Businesses
Table 97. Teva Pharmaceutical TDS(Transdermal Delivery Systems) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Teva Pharmaceutical Product
Table 99. Teva Pharmaceutical Recent Development
Table 100. Pfizer Corporation Information
Table 101. Pfizer Description and Major Businesses
Table 102. Pfizer TDS(Transdermal Delivery Systems) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Pfizer Product
Table 104. Pfizer Recent Development
Table 105. IBSA Group Corporation Information
Table 106. IBSA Group Description and Major Businesses
Table 107. IBSA Group TDS(Transdermal Delivery Systems) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. IBSA Group Product
Table 109. IBSA Group Recent Development
Table 110. Teikoku Seiyaku Corporation Information
Table 111. Teikoku Seiyaku Description and Major Businesses
Table 112. Teikoku Seiyaku TDS(Transdermal Delivery Systems) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Teikoku Seiyaku Product
Table 114. Teikoku Seiyaku Recent Development
Table 115. Endo International Corporation Information
Table 116. Endo International Description and Major Businesses
Table 117. Endo International TDS(Transdermal Delivery Systems) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Endo International Product
Table 119. Endo International Recent Development
Table 120. Hisamitsu Corporation Information
Table 121. Hisamitsu Description and Major Businesses
Table 122. Hisamitsu TDS(Transdermal Delivery Systems) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Hisamitsu Product
Table 124. Hisamitsu Recent Development
Table 125. Mylan Corporation Information
Table 126. Mylan Description and Major Businesses
Table 127. Mylan TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Mylan Product
Table 129. Mylan Recent Development
Table 130. Sorrento Therapeutics Corporation Information
Table 131. Sorrento Therapeutics Description and Major Businesses
Table 132. Sorrento Therapeutics TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Sorrento Therapeutics Product
Table 134. Sorrento Therapeutics Recent Development
Table 135. Global TDS(Transdermal Delivery Systems) Sales Forecast by Regions (2021-2026) (K Units)
Table 136. Global TDS(Transdermal Delivery Systems) Sales Market Share Forecast by Regions (2021-2026)
Table 137. Global TDS(Transdermal Delivery Systems) Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 138. Global TDS(Transdermal Delivery Systems) Revenue Market Share Forecast by Regions (2021-2026)
Table 139. North America: TDS(Transdermal Delivery Systems) Sales Forecast by Country (2021-2026) (K Units)
Table 140. North America: TDS(Transdermal Delivery Systems) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Europe: TDS(Transdermal Delivery Systems) Sales Forecast by Country (2021-2026) (K Units)
Table 142. Europe: TDS(Transdermal Delivery Systems) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Asia Pacific: TDS(Transdermal Delivery Systems) Sales Forecast by Region (2021-2026) (K Units)
Table 144. Asia Pacific: TDS(Transdermal Delivery Systems) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 145. Latin America: TDS(Transdermal Delivery Systems) Sales Forecast by Country (2021-2026) (K Units)
Table 146. Latin America: TDS(Transdermal Delivery Systems) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Middle East and Africa: TDS(Transdermal Delivery Systems) Sales Forecast by Country (2021-2026) (K Units)
Table 148. Middle East and Africa: TDS(Transdermal Delivery Systems) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 149. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 150. Key Challenges
Table 151. Market Risks
Table 152. Main Points Interviewed from Key TDS(Transdermal Delivery Systems) Players
Table 153. TDS(Transdermal Delivery Systems) Customers List
Table 154. TDS(Transdermal Delivery Systems) Distributors List
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
Table 1. TDS(Transdermal Delivery Systems) Market Segments
Table 2. Ranking of Global Top TDS(Transdermal Delivery Systems) Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global TDS(Transdermal Delivery Systems) Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Single-layer Drug-in-Adhesive
Table 5. Major Manufacturers of Multi-layer Drug-in-Adhesive
Table 6. Major Manufacturers of Others
Table 7. COVID-19 Impact Global Market: (Four TDS(Transdermal Delivery Systems) Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for TDS(Transdermal Delivery Systems) Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for TDS(Transdermal Delivery Systems) Players to Combat Covid-19 Impact
Table 12. Global TDS(Transdermal Delivery Systems) Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global TDS(Transdermal Delivery Systems) Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 14. Global TDS(Transdermal Delivery Systems) Sales by Regions 2015-2020 (K Units)
Table 15. Global TDS(Transdermal Delivery Systems) Sales Market Share by Regions (2015-2020)
Table 16. Global TDS(Transdermal Delivery Systems) Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global TDS(Transdermal Delivery Systems) Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global TDS(Transdermal Delivery Systems) Sales Share by Manufacturers (2015-2020)
Table 19. Global TDS(Transdermal Delivery Systems) Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global TDS(Transdermal Delivery Systems) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in TDS(Transdermal Delivery Systems) as of 2019)
Table 21. TDS(Transdermal Delivery Systems) Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. TDS(Transdermal Delivery Systems) Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers TDS(Transdermal Delivery Systems) Price (2015-2020) (USD/Unit)
Table 24. TDS(Transdermal Delivery Systems) Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers TDS(Transdermal Delivery Systems) Product Type
Table 26. Date of International Manufacturers Enter into TDS(Transdermal Delivery Systems) Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global TDS(Transdermal Delivery Systems) Sales by Type (2015-2020) (K Units)
Table 29. Global TDS(Transdermal Delivery Systems) Sales Share by Type (2015-2020)
Table 30. Global TDS(Transdermal Delivery Systems) Revenue by Type (2015-2020) (US$ Million)
Table 31. Global TDS(Transdermal Delivery Systems) Revenue Share by Type (2015-2020)
Table 32. TDS(Transdermal Delivery Systems) Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 33. Global TDS(Transdermal Delivery Systems) Sales by Application (2015-2020) (K Units)
Table 34. Global TDS(Transdermal Delivery Systems) Sales Share by Application (2015-2020)
Table 35. North America TDS(Transdermal Delivery Systems) Sales by Country (2015-2020) (K Units)
Table 36. North America TDS(Transdermal Delivery Systems) Sales Market Share by Country (2015-2020)
Table 37. North America TDS(Transdermal Delivery Systems) Revenue by Country (2015-2020) (US$ Million)
Table 38. North America TDS(Transdermal Delivery Systems) Revenue Market Share by Country (2015-2020)
Table 39. North America TDS(Transdermal Delivery Systems) Sales by Type (2015-2020) (K Units)
Table 40. North America TDS(Transdermal Delivery Systems) Sales Market Share by Type (2015-2020)
Table 41. North America TDS(Transdermal Delivery Systems) Sales by Application (2015-2020) (K Units)
Table 42. North America TDS(Transdermal Delivery Systems) Sales Market Share by Application (2015-2020)
Table 43. Europe TDS(Transdermal Delivery Systems) Sales by Country (2015-2020) (K Units)
Table 44. Europe TDS(Transdermal Delivery Systems) Sales Market Share by Country (2015-2020)
Table 45. Europe TDS(Transdermal Delivery Systems) Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe TDS(Transdermal Delivery Systems) Revenue Market Share by Country (2015-2020)
Table 47. Europe TDS(Transdermal Delivery Systems) Sales by Type (2015-2020) (K Units)
Table 48. Europe TDS(Transdermal Delivery Systems) Sales Market Share by Type (2015-2020)
Table 49. Europe TDS(Transdermal Delivery Systems) Sales by Application (2015-2020) (K Units)
Table 50. Europe TDS(Transdermal Delivery Systems) Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific TDS(Transdermal Delivery Systems) Sales by Region (2015-2020) (K Units)
Table 52. Asia Pacific TDS(Transdermal Delivery Systems) Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific TDS(Transdermal Delivery Systems) Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific TDS(Transdermal Delivery Systems) Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific TDS(Transdermal Delivery Systems) Sales by Type (2015-2020) (K Units)
Table 56. Asia Pacific TDS(Transdermal Delivery Systems) Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific TDS(Transdermal Delivery Systems) Sales by Application (2015-2020) (K Units)
Table 58. Asia Pacific TDS(Transdermal Delivery Systems) Sales Market Share by Application (2015-2020)
Table 59. Latin America TDS(Transdermal Delivery Systems) Sales by Country (2015-2020) (K Units)
Table 60. Latin America TDS(Transdermal Delivery Systems) Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa TDS(Transdermal Delivery Systems) Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America TDS(Transdermal Delivery Systems) Revenue Market Share by Country (2015-2020)
Table 63. Latin America TDS(Transdermal Delivery Systems) Sales by Type (2015-2020) (K Units)
Table 64. Latin America TDS(Transdermal Delivery Systems) Sales Market Share by Type (2015-2020)
Table 65. Latin America TDS(Transdermal Delivery Systems) Sales by Application (2015-2020) (K Units)
Table 66. Latin America TDS(Transdermal Delivery Systems) Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa TDS(Transdermal Delivery Systems) Sales by Country (2015-2020) (K Units)
Table 68. Middle East and Africa TDS(Transdermal Delivery Systems) Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa TDS(Transdermal Delivery Systems) Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa TDS(Transdermal Delivery Systems) Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa TDS(Transdermal Delivery Systems) Sales by Type (2015-2020) (K Units)
Table 72. Middle East and Africa TDS(Transdermal Delivery Systems) Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa TDS(Transdermal Delivery Systems) Sales by Application (2015-2020) (K Units)
Table 74. Middle East and Africa TDS(Transdermal Delivery Systems) Sales Market Share by Application (2015-2020)
Table 75. Adhex Pharma Corporation Information
Table 76. Adhex Pharma Description and Major Businesses
Table 77. Adhex Pharma TDS(Transdermal Delivery Systems) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Adhex Pharma Product
Table 79. Adhex Pharma Recent Development
Table 80. Harro Hofliger Corporation Information
Table 81. Harro Hofliger Description and Major Businesses
Table 82. Harro Hofliger TDS(Transdermal Delivery Systems) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Harro Hofliger Product
Table 84. Harro Hofliger Recent Development
Table 85. Tesa Labtec Corporation Information
Table 86. Tesa Labtec Description and Major Businesses
Table 87. Tesa Labtec TDS(Transdermal Delivery Systems) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Tesa Labtec Product
Table 89. Tesa Labtec Recent Development
Table 90. Toyochem Corporation Information
Table 91. Toyochem Description and Major Businesses
Table 92. Toyochem TDS(Transdermal Delivery Systems) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Toyochem Product
Table 94. Toyochem Recent Development
Table 95. Teva Pharmaceutical Corporation Information
Table 96. Teva Pharmaceutical Description and Major Businesses
Table 97. Teva Pharmaceutical TDS(Transdermal Delivery Systems) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Teva Pharmaceutical Product
Table 99. Teva Pharmaceutical Recent Development
Table 100. Pfizer Corporation Information
Table 101. Pfizer Description and Major Businesses
Table 102. Pfizer TDS(Transdermal Delivery Systems) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Pfizer Product
Table 104. Pfizer Recent Development
Table 105. IBSA Group Corporation Information
Table 106. IBSA Group Description and Major Businesses
Table 107. IBSA Group TDS(Transdermal Delivery Systems) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. IBSA Group Product
Table 109. IBSA Group Recent Development
Table 110. Teikoku Seiyaku Corporation Information
Table 111. Teikoku Seiyaku Description and Major Businesses
Table 112. Teikoku Seiyaku TDS(Transdermal Delivery Systems) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Teikoku Seiyaku Product
Table 114. Teikoku Seiyaku Recent Development
Table 115. Endo International Corporation Information
Table 116. Endo International Description and Major Businesses
Table 117. Endo International TDS(Transdermal Delivery Systems) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Endo International Product
Table 119. Endo International Recent Development
Table 120. Hisamitsu Corporation Information
Table 121. Hisamitsu Description and Major Businesses
Table 122. Hisamitsu TDS(Transdermal Delivery Systems) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Hisamitsu Product
Table 124. Hisamitsu Recent Development
Table 125. Mylan Corporation Information
Table 126. Mylan Description and Major Businesses
Table 127. Mylan TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Mylan Product
Table 129. Mylan Recent Development
Table 130. Sorrento Therapeutics Corporation Information
Table 131. Sorrento Therapeutics Description and Major Businesses
Table 132. Sorrento Therapeutics TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Sorrento Therapeutics Product
Table 134. Sorrento Therapeutics Recent Development
Table 135. Global TDS(Transdermal Delivery Systems) Sales Forecast by Regions (2021-2026) (K Units)
Table 136. Global TDS(Transdermal Delivery Systems) Sales Market Share Forecast by Regions (2021-2026)
Table 137. Global TDS(Transdermal Delivery Systems) Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 138. Global TDS(Transdermal Delivery Systems) Revenue Market Share Forecast by Regions (2021-2026)
Table 139. North America: TDS(Transdermal Delivery Systems) Sales Forecast by Country (2021-2026) (K Units)
Table 140. North America: TDS(Transdermal Delivery Systems) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Europe: TDS(Transdermal Delivery Systems) Sales Forecast by Country (2021-2026) (K Units)
Table 142. Europe: TDS(Transdermal Delivery Systems) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Asia Pacific: TDS(Transdermal Delivery Systems) Sales Forecast by Region (2021-2026) (K Units)
Table 144. Asia Pacific: TDS(Transdermal Delivery Systems) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 145. Latin America: TDS(Transdermal Delivery Systems) Sales Forecast by Country (2021-2026) (K Units)
Table 146. Latin America: TDS(Transdermal Delivery Systems) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Middle East and Africa: TDS(Transdermal Delivery Systems) Sales Forecast by Country (2021-2026) (K Units)
Table 148. Middle East and Africa: TDS(Transdermal Delivery Systems) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 149. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 150. Key Challenges
Table 151. Market Risks
Table 152. Main Points Interviewed from Key TDS(Transdermal Delivery Systems) Players
Table 153. TDS(Transdermal Delivery Systems) Customers List
Table 154. TDS(Transdermal Delivery Systems) Distributors List
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. TDS(Transdermal Delivery Systems) Product Picture
Figure 2. Global TDS(Transdermal Delivery Systems) Sales Market Share by Type in 2020 & 2026
Figure 3. Single-layer Drug-in-Adhesive Product Picture
Figure 4. Multi-layer Drug-in-Adhesive Product Picture
Figure 5. Others Product Picture
Figure 6. Global TDS(Transdermal Delivery Systems) Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Other
Figure 10. TDS(Transdermal Delivery Systems) Report Years Considered
Figure 11. Global TDS(Transdermal Delivery Systems) Market Size 2015-2026 (US$ Million)
Figure 12. Global TDS(Transdermal Delivery Systems) Sales 2015-2026 (K Units)
Figure 13. Global TDS(Transdermal Delivery Systems) Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global TDS(Transdermal Delivery Systems) Sales Market Share by Region (2015-2020)
Figure 15. Global TDS(Transdermal Delivery Systems) Sales Market Share by Region in 2019
Figure 16. Global TDS(Transdermal Delivery Systems) Revenue Market Share by Region (2015-2020)
Figure 17. Global TDS(Transdermal Delivery Systems) Revenue Market Share by Region in 2019
Figure 18. Global TDS(Transdermal Delivery Systems) Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by TDS(Transdermal Delivery Systems) Revenue in 2019
Figure 20. TDS(Transdermal Delivery Systems) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global TDS(Transdermal Delivery Systems) Sales Market Share by Type (2015-2020)
Figure 22. Global TDS(Transdermal Delivery Systems) Sales Market Share by Type in 2019
Figure 23. Global TDS(Transdermal Delivery Systems) Revenue Market Share by Type (2015-2020)
Figure 24. Global TDS(Transdermal Delivery Systems) Revenue Market Share by Type in 2019
Figure 25. Global TDS(Transdermal Delivery Systems) Market Share by Price Range (2015-2020)
Figure 26. Global TDS(Transdermal Delivery Systems) Sales Market Share by Application (2015-2020)
Figure 27. Global TDS(Transdermal Delivery Systems) Sales Market Share by Application in 2019
Figure 28. Global TDS(Transdermal Delivery Systems) Revenue Market Share by Application (2015-2020)
Figure 29. Global TDS(Transdermal Delivery Systems) Revenue Market Share by Application in 2019
Figure 30. North America TDS(Transdermal Delivery Systems) Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America TDS(Transdermal Delivery Systems) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America TDS(Transdermal Delivery Systems) Sales Market Share by Country in 2019
Figure 33. North America TDS(Transdermal Delivery Systems) Revenue Market Share by Country in 2019
Figure 34. U.S. TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America TDS(Transdermal Delivery Systems) Market Share by Type in 2019
Figure 39. North America TDS(Transdermal Delivery Systems) Market Share by Application in 2019
Figure 40. Europe TDS(Transdermal Delivery Systems) Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe TDS(Transdermal Delivery Systems) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe TDS(Transdermal Delivery Systems) Sales Market Share by Country in 2019
Figure 43. Europe TDS(Transdermal Delivery Systems) Revenue Market Share by Country in 2019
Figure 44. Germany TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 47. France TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe TDS(Transdermal Delivery Systems) Market Share by Type in 2019
Figure 55. Europe TDS(Transdermal Delivery Systems) Market Share by Application in 2019
Figure 56. Asia Pacific TDS(Transdermal Delivery Systems) Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific TDS(Transdermal Delivery Systems) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific TDS(Transdermal Delivery Systems) Sales Market Share by Region in 2019
Figure 59. Asia Pacific TDS(Transdermal Delivery Systems) Revenue Market Share by Region in 2019
Figure 60. China TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 61. China TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 67. India TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific TDS(Transdermal Delivery Systems) Market Share by Type in 2019
Figure 83. Asia Pacific TDS(Transdermal Delivery Systems) Market Share by Application in 2019
Figure 84. Latin America TDS(Transdermal Delivery Systems) Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America TDS(Transdermal Delivery Systems) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America TDS(Transdermal Delivery Systems) Sales Market Share by Country in 2019
Figure 87. Latin America TDS(Transdermal Delivery Systems) Revenue Market Share by Country in 2019
Figure 88. Mexico TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America TDS(Transdermal Delivery Systems) Market Share by Type in 2019
Figure 95. Latin America TDS(Transdermal Delivery Systems) Market Share by Application in 2019
Figure 96. Middle East and Africa TDS(Transdermal Delivery Systems) Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa TDS(Transdermal Delivery Systems) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa TDS(Transdermal Delivery Systems) Sales Market Share by Country in 2019
Figure 99. Middle East and Africa TDS(Transdermal Delivery Systems) Revenue Market Share by Country in 2019
Figure 100. Turkey TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa TDS(Transdermal Delivery Systems) Market Share by Type in 2019
Figure 107. Middle East and Africa TDS(Transdermal Delivery Systems) Market Share by Application in 2019
Figure 108. Adhex Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Harro Hofliger Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Tesa Labtec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Toyochem Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. IBSA Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Teikoku Seiyaku Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Endo International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Hisamitsu Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Sorrento Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. North America TDS(Transdermal Delivery Systems) Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. North America TDS(Transdermal Delivery Systems) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Europe TDS(Transdermal Delivery Systems) Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 123. Europe TDS(Transdermal Delivery Systems) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Asia Pacific TDS(Transdermal Delivery Systems) Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 125. Asia Pacific TDS(Transdermal Delivery Systems) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Latin America TDS(Transdermal Delivery Systems) Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 127. Latin America TDS(Transdermal Delivery Systems) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Middle East and Africa TDS(Transdermal Delivery Systems) Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 129. Middle East and Africa TDS(Transdermal Delivery Systems) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Porter's Five Forces Analysis
Figure 131. Channels of Distribution
Figure 132. Distributors Profiles
Figure 133. Bottom-up and Top-down Approaches for This Report
Figure 134. Data Triangulation
Figure 135. Key Executives Interviewed
Figure 1. TDS(Transdermal Delivery Systems) Product Picture
Figure 2. Global TDS(Transdermal Delivery Systems) Sales Market Share by Type in 2020 & 2026
Figure 3. Single-layer Drug-in-Adhesive Product Picture
Figure 4. Multi-layer Drug-in-Adhesive Product Picture
Figure 5. Others Product Picture
Figure 6. Global TDS(Transdermal Delivery Systems) Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Other
Figure 10. TDS(Transdermal Delivery Systems) Report Years Considered
Figure 11. Global TDS(Transdermal Delivery Systems) Market Size 2015-2026 (US$ Million)
Figure 12. Global TDS(Transdermal Delivery Systems) Sales 2015-2026 (K Units)
Figure 13. Global TDS(Transdermal Delivery Systems) Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global TDS(Transdermal Delivery Systems) Sales Market Share by Region (2015-2020)
Figure 15. Global TDS(Transdermal Delivery Systems) Sales Market Share by Region in 2019
Figure 16. Global TDS(Transdermal Delivery Systems) Revenue Market Share by Region (2015-2020)
Figure 17. Global TDS(Transdermal Delivery Systems) Revenue Market Share by Region in 2019
Figure 18. Global TDS(Transdermal Delivery Systems) Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by TDS(Transdermal Delivery Systems) Revenue in 2019
Figure 20. TDS(Transdermal Delivery Systems) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global TDS(Transdermal Delivery Systems) Sales Market Share by Type (2015-2020)
Figure 22. Global TDS(Transdermal Delivery Systems) Sales Market Share by Type in 2019
Figure 23. Global TDS(Transdermal Delivery Systems) Revenue Market Share by Type (2015-2020)
Figure 24. Global TDS(Transdermal Delivery Systems) Revenue Market Share by Type in 2019
Figure 25. Global TDS(Transdermal Delivery Systems) Market Share by Price Range (2015-2020)
Figure 26. Global TDS(Transdermal Delivery Systems) Sales Market Share by Application (2015-2020)
Figure 27. Global TDS(Transdermal Delivery Systems) Sales Market Share by Application in 2019
Figure 28. Global TDS(Transdermal Delivery Systems) Revenue Market Share by Application (2015-2020)
Figure 29. Global TDS(Transdermal Delivery Systems) Revenue Market Share by Application in 2019
Figure 30. North America TDS(Transdermal Delivery Systems) Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America TDS(Transdermal Delivery Systems) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America TDS(Transdermal Delivery Systems) Sales Market Share by Country in 2019
Figure 33. North America TDS(Transdermal Delivery Systems) Revenue Market Share by Country in 2019
Figure 34. U.S. TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America TDS(Transdermal Delivery Systems) Market Share by Type in 2019
Figure 39. North America TDS(Transdermal Delivery Systems) Market Share by Application in 2019
Figure 40. Europe TDS(Transdermal Delivery Systems) Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe TDS(Transdermal Delivery Systems) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe TDS(Transdermal Delivery Systems) Sales Market Share by Country in 2019
Figure 43. Europe TDS(Transdermal Delivery Systems) Revenue Market Share by Country in 2019
Figure 44. Germany TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 47. France TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe TDS(Transdermal Delivery Systems) Market Share by Type in 2019
Figure 55. Europe TDS(Transdermal Delivery Systems) Market Share by Application in 2019
Figure 56. Asia Pacific TDS(Transdermal Delivery Systems) Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific TDS(Transdermal Delivery Systems) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific TDS(Transdermal Delivery Systems) Sales Market Share by Region in 2019
Figure 59. Asia Pacific TDS(Transdermal Delivery Systems) Revenue Market Share by Region in 2019
Figure 60. China TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 61. China TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 67. India TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific TDS(Transdermal Delivery Systems) Market Share by Type in 2019
Figure 83. Asia Pacific TDS(Transdermal Delivery Systems) Market Share by Application in 2019
Figure 84. Latin America TDS(Transdermal Delivery Systems) Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America TDS(Transdermal Delivery Systems) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America TDS(Transdermal Delivery Systems) Sales Market Share by Country in 2019
Figure 87. Latin America TDS(Transdermal Delivery Systems) Revenue Market Share by Country in 2019
Figure 88. Mexico TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America TDS(Transdermal Delivery Systems) Market Share by Type in 2019
Figure 95. Latin America TDS(Transdermal Delivery Systems) Market Share by Application in 2019
Figure 96. Middle East and Africa TDS(Transdermal Delivery Systems) Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa TDS(Transdermal Delivery Systems) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa TDS(Transdermal Delivery Systems) Sales Market Share by Country in 2019
Figure 99. Middle East and Africa TDS(Transdermal Delivery Systems) Revenue Market Share by Country in 2019
Figure 100. Turkey TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E TDS(Transdermal Delivery Systems) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa TDS(Transdermal Delivery Systems) Market Share by Type in 2019
Figure 107. Middle East and Africa TDS(Transdermal Delivery Systems) Market Share by Application in 2019
Figure 108. Adhex Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Harro Hofliger Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Tesa Labtec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Toyochem Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. IBSA Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Teikoku Seiyaku Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Endo International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Hisamitsu Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Sorrento Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. North America TDS(Transdermal Delivery Systems) Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. North America TDS(Transdermal Delivery Systems) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Europe TDS(Transdermal Delivery Systems) Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 123. Europe TDS(Transdermal Delivery Systems) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Asia Pacific TDS(Transdermal Delivery Systems) Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 125. Asia Pacific TDS(Transdermal Delivery Systems) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Latin America TDS(Transdermal Delivery Systems) Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 127. Latin America TDS(Transdermal Delivery Systems) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Middle East and Africa TDS(Transdermal Delivery Systems) Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 129. Middle East and Africa TDS(Transdermal Delivery Systems) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Porter's Five Forces Analysis
Figure 131. Channels of Distribution
Figure 132. Distributors Profiles
Figure 133. Bottom-up and Top-down Approaches for This Report
Figure 134. Data Triangulation
Figure 135. Key Executives Interviewed
